Posted on 12/11/2015
Early in June, we reported that General Electric's Healthcare division had received FDA approval for its 3-D Invenia Automated Breast Ultrasound System (ABUS), a next-generation ultrasound breast imaging technology said to detect a third more cancers in women with dense breasts than mammograms alone.
Now, in an analysis of nearly half a million women published in the June 25 issue of the Journal of the American Medical Association (JAMA), researchers have found that 3-D x-ray mammography, or tomosynthesis, combined with traditional x-ray screening, was linked to a 41 percent increase in the detection of invasive cancers as well as a 15 percent drop in the recall rate...